Crossmark

Silencing of adipocyte enhancer-binding protein 1 (AEBP1) alleviates renal fibrosis in vivo and in vitro via inhibition of the β-catenin signaling pathway

Crossref DOI link: https://doi.org/10.1007/s13577-023-00859-w

Published Online: 2023-02-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Naiquan

Liu, Dajun https://orcid.org/0000-0002-2891-4846
Cao, Shiyu

Lei, Jing
License Information

Text and Data Mining valid from 2023-02-04

Version of Record valid from 2023-02-04
More Information

Article History

Received: 12 July 2022

Accepted: 17 January 2023

First Online: 4 February 2023

Declarations

:

: The authors declare that they have no competing interests.

: All animal experiments were in compliance with the Guide for the Care and Use of Laboratory Animals of Shengjing Hospital of China Medical University, and ethical approval was granted by the Medical Ethics Committee of Shengjing Hospital of China Medical University (No. 2022PS600K, Shenyang, China).

: This study does not involve any human participants.

Document is current

Any future updates will be listed below